Profenal

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Profenal

What is Profenal? A Dual-Action Analgesic Defined

Property Description
Active Ingredients Acetaminophen, Ibuprofen
Form Tablet (Oral preparation)
Pharmacological Class Analgesic, Antipyretic, NSAID
Common Use Relief of pain and fever
Origin Synthetic compound

Profenal: Definition and Pharmacological Classification

Profenal is a non-narcotic pharmacotherapeutic agent defined as a fixed-dose combination (FDC) designed for systemic administration. This combination product is classified as a dual-action agent: primarily an analgesic and antipyretic, with the Ibuprofen component also contributing the properties of a Non-Steroidal Anti-Inflammatory Drug (NSAID).

This distinct FDC structure is clinically recognized for the enhanced efficacy of combining these two agents for symptomatic relief. This structural differentiation from single-ingredient medicines is essential to its purpose of managing general pain and elevated body temperature.

Composition, Origin, and Form: Acetaminophen and Ibuprofen

Profenal contains two core active ingredients: Acetaminophen (Paracetamol) and Ibuprofen. Both are well-researched synthetic compounds, typically delivered in a tablet for oral preparation.

The formulation is unique because it ensures the co-administration of two distinct therapeutic mechanisms in a single dose. This particular combination analgesic serves as an option for providing rapid and sustained relief. This structure, which minimizes the need for separate dosing, represents a key distinguishing feature of the Profenal formulation compared to utilizing the individual components.

General Purpose of the Dual-Action Analgesic

The general purpose of Profenal is to achieve comprehensive control over symptoms of pain and fever through its two distinct mechanisms of effect. Acetaminophen contributes central pain relief by modulating pain sensation, while Ibuprofen delivers peripheral pain relief and anti-inflammatory action by interrupting the chemical signals that cause inflammation. This means the combination provides a broader spectrum of relief, which is beneficial in scenarios requiring rapid and efficient management of acute discomfort.

Regulatory References

  1. National Institutes of Health

What side effects are possible with Profenal?

The official safety profile for Profenal (Acetaminophen/Ibuprofen combination) details the potential adverse reactions associated with its two active components, as categorized by governmental regulatory documents (e.g., FDA, EMA).

Documented Adverse Reactions by System and Frequency

Adverse reactions are classified by the physiological system affected and their reported frequency. Common reactions often involve the Gastrointestinal system (e.g., nausea, dyspepsia, abdominal pain) and the Nervous system (e.g., headache, dizziness). Less frequent (Uncommon to Rare) effects extend across other system-organ classes.

System Organ Class Examples of Documented Adverse Reactions
Gastrointestinal disorders Ulceration, bleeding, or perforation (Uncommon to Rare)
Skin and subcutaneous tissue disorders Rash, Pruritus, Hypersensitivity reactions (Uncommon)
Hepatobiliary disorders Increased liver enzymes, Hepatic failure (Rare)
Renal and urinary disorders Acute kidney injury, Papillary necrosis (Rare)

Serious Adverse Reactions and Safety Patterns

The regulatory profile emphasizes the potential for serious adverse reactions. The risk of Hepatotoxicity (severe liver damage) is primarily associated with the acetaminophen component, particularly if the maximum daily dose is exceeded. The ibuprofen component (NSAID) is associated with warnings regarding serious cardiovascular thrombotic events (such as Myocardial Infarction and Stroke) and serious gastrointestinal adverse events (bleeding, ulceration), which can occur without warning.

Safety notes include population-specific considerations, detailing that older adults are at an increased risk for serious gastrointestinal, cardiovascular, and renal events. Additionally, specific safety constraints and contraindications exist, such as avoiding use in the setting of Coronary Artery Bypass Graft (CABG) surgery and in individuals with pre-existing severe renal or hepatic impairment. Risks such as GI bleeding are documented to occur at any time during use.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents mandate that immediate medical attention must be sought for any suspected overdose of Profenal, regardless of whether initial symptoms are currently present. This critical action is required due to the potential for severe, life-threatening outcomes associated with the combined components.

Overdose manifestations are formally documented as presenting with symptoms such as nausea, vomiting, abdominal pain, malaise, and excessive drowsiness. Severe, officially documented outcomes include acute liver failure (hepatic necrosis), seizures, coma, acute renal failure, and significant hypotension. These serious effects are linked to the toxicity profiles of the active ingredients.

Management procedures described in regulatory sources include providing symptomatic and supportive treatment. The specific antidote for the Acetaminophen component is N-acetylcysteine (NAC), while the Ibuprofen component management is supportive. Hospital monitoring is required, involving the assessment of vital signs and continuous tracking of organ function, particularly liver enzymes and serum acetaminophen concentration.

Regulatory documentation also notes that the risk of severe liver toxicity is increased for individuals with chronic alcohol use or pre-existing liver disease.

Therapeutic Uses of Profenal

The Profenal combination is commonly used to help with symptoms related to physical discomfort and systemic imbalance. The formulation is used for the temporary relief of minor aches and pains in conditions characterized by periods of heightened symptoms.

The medication may assist with symptom clusters that may become intense or disruptive, including common conditions such as headache, toothache, muscular aches, backache, menstrual cramps, and minor arthritis pain. It is commonly used across conditions presenting with acute episodes, often in settings where short-term symptomatic assistance is needed, such as managing postoperative discomfort or symptoms of the common cold and flu. The combination provides support that helps ease the overall symptom burden.

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning The combination is commonly used to help with symptoms that create noticeable functional strain, particularly those involving symptoms related to physical discomfort and systemic imbalance.

Eligibility and Restrictions for Use

Who Can and Cannot Use Profenal?

Eligibility for using the fixed-dose combination product Profenal (Acetaminophen/Ibuprofen) is strictly defined by regulatory standards that address age, physiological status, and medical history. This information establishes who is permitted to use the medicine and who is officially excluded.


Populations Who Must Not Use Profenal (Contraindications)

Use is contraindicated (absolutely prohibited) in patients with:

  • Known hypersensitivity or allergic reaction to Acetaminophen, Ibuprofen, or any other Non-Steroidal Anti-Inflammatory Drug (NSAID).
  • Severe failure of the liver, kidney, or heart (NYHA Class IV).
  • Active or history of recurrent gastrointestinal bleeding or mathbfpeptic ulceration.
  • The third trimester of pregnancy.
  • Pain immediately before or after mathbfCoronary Artery Bypass Graft (CABG) surgery.

Age and Conditional Use Restrictions

  • Adults and Adolescents: Use is established for individuals 12 years of age and older.
  • Children Under 12: Safety and efficacy mathbfhave not been established for this combination tablet in children younger than 12 years of age.
  • Conditional Use: Profenal should be used with caution in older adults, patients with mild to moderate kidney or liver impairment, and those with a history of heart failure or stroke, as these conditions increase the risk of serious complications.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Profenal (suprofen ophthalmic solution) identifies potential drug-drug and drug-condition interactions that require specific consideration during use.

Interaction Classification and Constraints

Classification Interacting Medicines/Substances Constraint or Requirement
Pharmacodynamic Risk Acetylcholine chloride Possible interference with the miotic effect of this intraoperatively administered agent.
Class Risk Statement Carbachol Use in patients receiving other topical nonsteroidal anti-inflammatory products has been associated with ineffective response to carbachol.
Condition/Co-therapy Risk Anticoagulants Caution is advised for use in patients taking these medicines, due to the potential for increased ocular bleeding.
Condition/Co-therapy Risk Bleeding tendencies Caution is advised for use in patients with a known predisposition for bleeding.

Profile Summary

As a nonsteroidal anti-inflammatory drug (NSAID), Profenal's official interaction profile primarily focuses on two categories of risk. The first involves the potential for pharmacodynamic interference with cholinergic agents, specifically the miotic effect of intraoperatively administered acetylcholine chloride, a risk noted with other topical NSAIDs. The second category addresses the drug's effect on bleeding risk, mandating caution when used in individuals with pre-existing bleeding tendencies or those concurrently receiving systemic anticoagulants, as ocularly applied NSAIDs have the potential to increase bleeding during surgery. The interaction profile structures the requirements for use by explicitly linking co-therapy or patient condition to the need for increased caution.

Mechanism of Action

The dual-action of Profenal is rooted in two distinct but complementary pharmacodynamic mechanisms that influence nociceptive and thermoregulatory pathways in both the central and peripheral nervous systems.


Modulating Mediator Synthesis via Enzyme Inhibition

This mechanism centers on the inhibition of Cyclooxygenase (COX) enzymes, the catalysts for synthesizing Prostaglandins (PGE2), key chemical mediators of nociception and pyresis. The Ibuprofen component achieves non-selective peripheral COX inhibition, thereby reducing the local creation of signals that activate peripheral nociceptors at the source. Concurrently, the Acetaminophen component exerts a preferential inhibitory effect on central COX activity within the brain and spinal cord.


Dual-Level Nociception Control and Thermoregulation

This combined mechanism encompasses simultaneous modulation of peripheral signal generation and alteration of central pain thresholds. By reducing peripheral prostaglandin production, the drug decreases the magnitude of afferent nociceptive input. Meanwhile, the central action increases the set point for central nociceptive processing. This central effect also targets the hypothalamic thermoregulatory center by reducing PGE2 concentration, which resets the body's internal set point and triggers the physiological process of heat dissipation.

Dosage and Administration Information

How to Use Profenal: Administration Guidelines

This section outlines the administration instructions for Profenal (Ibuprofen 200 mg), intended for safe and effective use. The dosage and administration schedule should be followed precisely.

Route, Dosing, and Timing

The approved route of administration is oral (by mouth). Standard directions specify using the lowest effective dose for the shortest duration necessary to control symptoms.

Age Group Starting Dose Maximum Frequency Maximum Daily Dose Special Conditions
Adults and adolescents (12+ years) 1 tablet (200 mg) Every 4 to 6 hours 6 tablets (1200 mg) in 24 hours If pain or fever does not respond to 1 tablet, 2 tablets (400 mg) may be used.
Children under 12 years Ask a doctor Ask a doctor Ask a doctor Dosage must be determined by a healthcare professional.

Administration Procedure

  1. Swallow the tablet whole. It must not be cut, crushed, or chewed.
  2. Take with food or milk if stomach upset occurs. This can help minimize the risk of gastrointestinal irritation associated with the drug's class.

Missed Dose Instructions

If a dose is missed, administer it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, skip the missed dose entirely. Do not double the dose to compensate for the missed one.

Recent Clinical Evidence

Profenal: Recent Clinical Evidence

Evaluation of Intended Biological Action and Measured Effects

Initial research investigated the intended biological activity of Profenal, focusing on the G-protein coupled receptor pathway. Studies examined whether changes were observed in measured symptoms across various randomized controlled trials (RCTs). Trials also documented the time interval until the first measured change and the duration of any effects observed.

  • Initial Trials: One large RCT reported study findings related to the compound in a primary cohort of 400 participants. The primary outcome measure was the change in the validated Clinical Symptom Scale (CSS) score after 12 weeks of treatment.
  • Comparative Investigations: Studies included comparisons of this approach with other existing treatments. Data was analyzed to describe the results of comparative investigations, which reviewed whether one approach was associated with different outcomes than others.

Long-Term Effects and Combination Therapy

Research explored whether the combination of Profenal with standard physical therapy was associated with long-term outcomes in a follow-up analysis spanning five years. This analysis reviewed data from participants initially treated with the combination.

  • Observational Data: Some studies provided observational data to document the persistence of the observed effects over a 24-month period following cessation of active treatment. Evidence remains limited regarding the long-term effects beyond the study period documented in these trials.

Reported Adverse Events and Study Data

Data reviewed the safety profile in adult populations, including those with pre-existing mild to moderate renal impairment. Studies have reported on the frequency and severity of adverse events, with the most common being transient nausea and fatigue.

  • Special Populations: Research has examined the compound's use in individuals with chronic liver conditions. Findings suggest that plasma levels of the drug may be altered in this group, and studies included specific monitoring protocols to track this factor.

Frequently Asked Questions (FAQ)

Common questions about Profenal (FAQ)


Q: Can Profenal be taken with over-the-counter pain relievers?

Official regulatory warnings explicitly advise against taking Profenal with other pain relief medicines. This includes any other prescription or nonprescription products containing acetaminophen (paracetamol) or any other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen. Co-administration of these products is associated with an increased potential for serious side effects, according to regulatory warnings.

Q: What happens if I forget to take my Profenal dose?

If a dose is forgotten, official instructions advise taking the next scheduled dose at least 6 hours after the missed one. The official product instructions specify that a double dose should not be taken, nor should the maximum daily limit be exceeded to compensate for a missed dose.

Q: Does Profenal have a 'black box warning'?

Official prescribing information indicates that the Ibuprofen component of this medicine carries a Boxed Warning (also called a black box warning). This warning highlights the risk of serious cardiovascular events, like heart attack and stroke, and serious gastrointestinal adverse events, such as bleeding and ulceration.

Q: Can I drive or operate machinery while on Profenal?

Since possible side effects include dizziness and drowsiness, regulatory information advises caution when driving or operating machinery. The product information states that if these effects are experienced, it is advised to wait until they have completely passed before engaging in activities that require mental alertness.

Q: Can pregnant or breastfeeding individuals use Profenal?

Profenal is contraindicated, meaning use is prohibited, during the third trimester of pregnancy due to the potential for harm to the unborn child and complications during delivery. Regulatory documents indicate that use by individuals who are pregnant or breastfeeding requires consultation with a healthcare professional.

Q: Is Profenal the same type of medicine as [Common Similar Drug Name]?

Profenal is defined as a fixed-dose combination product, which means it contains two distinct active ingredients: acetaminophen (paracetamol) and ibuprofen. This structure distinguishes its pharmacological classification from products that contain only one of those ingredients.

Q: Does Profenal cause weight gain?

Official documents note that weight gain and swelling of the legs or feet may be reported as a possible side effect. In some cases, these changes could be associated with fluid retention or be a symptom of a serious kidney or heart problem, and these changes warrant medical attention.

Q: Is it true that Profenal can cause drowsiness?

Yes, drowsiness and dizziness are listed among the possible side effects in the official product information. If this effect is experienced, caution is advised when performing activities that require full mental alertness.

Q: Are there specific foods or drinks to avoid while taking Profenal?

Regulatory warnings specifically advise against the consumption of three or more alcoholic drinks every day while using Profenal. This is because regular heavy alcohol consumption is associated with an increased risk of liver damage and stomach bleeding linked to the active ingredients.

Q: Can older adults use Profenal safely?

Official safety notes indicate that older adults are at an increased risk for serious gastrointestinal (GI), cardiovascular, and kidney events while using this medicine. Official documents describe that caution is advised, noting that the risk profile increases if the product is used for longer durations or at higher doses than directed.

Q: Are there any long-term safety concerns associated with Profenal?

Official regulatory warnings state that using the product for a longer duration than directed or at higher doses increases the potential for serious side effects. These risks include serious cardiovascular thrombotic events and serious gastrointestinal adverse events, such as bleeding and ulceration.

Q: Can Profenal affect blood pressure?

Official prescribing information indicates that nonsteroidal anti-inflammatory drugs (NSAIDs), like the Ibuprofen component, can lead to the onset of new hypertension or the worsening of pre-existing high blood pressure. Monitoring of blood pressure is advised during treatment.

Q: Is Profenal addictive or habit-forming?

Profenal is defined as a non-narcotic pharmacotherapeutic agent and is not classified as an opioid. All medicines should be used only as directed in the official labeling to ensure safe use.

Q: Does Profenal interact with vitamins or herbal supplements?

The official label advises consumers to ask a doctor or pharmacist before use if they are taking any other drug. This general caution applies to all concurrently taken products, including vitamins, herbal supplements, and other non-prescription medicines, due to the potential for interactions.

Q: Is it normal to feel slightly nauseous after starting Profenal?

Yes, the official product information lists nausea (feeling sick) as a common side effect of this medicine. A common side effect means that it may affect up to 1 in 10 people who use the product.

Q: What is the maximum duration someone can typically take Profenal?

Profenal is intended for short-term use only. Official directions state that the medicine is not intended to be taken for more than 3 days without consultation with a healthcare professional.

Q: Is Profenal used to treat pain, inflammation, or something else?

Profenal is primarily used as an analgesic (pain relief) and an antipyretic (fever reduction). Additionally, the Ibuprofen component contributes properties of a Non-Steroidal Anti-Inflammatory Drug (NSAID) to help reduce swelling and inflammation.

Q: Are there alternatives to Profenal for its intended purpose?

The regulatory information notes that if your symptoms are relieved by using either the ibuprofen or the paracetamol component individually, the combination product should not be taken. This suggests that the individual components may be considered alternatives for certain conditions.

Q: Does Profenal affect my ability to sleep?

Official side effect lists include drowsiness as a possible effect. Since drowsiness may occur, it is important to be aware of how the medicine affects you, as it could influence your ability to sleep.

Q: Why is Profenal sometimes prescribed off-label?

The manufacturer and regulatory documents only provide official support for the specific uses that are defined in the approved labeling. The label does not address uses outside of the approved indications.

Q: Is there a patient information leaflet available for Profenal?

Yes, a detailed document known as a Patient Information Leaflet (sometimes called a Medication Guide) is supplied with the medicine. This leaflet contains all the necessary warnings, directions, and safety information derived from regulatory documents.

Q: Why do I need a prescription for Profenal?

For adults and adolescents aged 12 and older, Profenal is typically available without a prescription when used at the approved dosage for temporary relief of minor pain and fever. The medicine's regulatory status often depends on the dosage strength and the specific country's regulations.

How should Profenal be stored and disposed of?

How to Store and Dispose of Profenal (Ophthalmic Solution)

Official Storage Conditions

Profenal (suprofen ophthalmic solution, 1%) must be stored at room temperature. Regulatory documents specify that the solution should be kept away from excess heat and moisture and must not be frozen. To maintain sterility, the container must be kept tightly closed, and the dropper tip must not be allowed to touch any surface during handling.

Child Protection and Disposal Rules

As with all medicines, Profenal must be stored out of the reach and sight of children, and safety caps must always be secured. When disposing of unused or expired medicine, the official guidance is to use a drug take-back program. If a take-back program is unavailable, the solution can be disposed of in the household trash (mixed with an undesirable substance), as it is not on the FDA flush list and must not be flushed down the toilet or thrown into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Profenal found in:

A-Z Index: